2. Bain throws down $3.3B to acquire Japan's Mitsubishi Tanabe Pharma After reports of buyout talks, Bain Capital has inked a deal to acquire Mitsubishi Tanabe Pharma from the Japanese drugmaker ...

TOKYO - U.S. private equity firm Bain Capital has bought Mitsubishi Tanabe Pharma in a deal worth 510 billion yen ($3.4 billion), saying it was encouraged by prospects of regulatory change for Japan's ...

Founded in 1678, Tanabe Pharma is headquartered in Doshomachi, Osaka, the birthplace of Japan’s pharmaceutical industry. Through the discovery and development of innovative drugs that address ...

Private equity firm Bain Capital agreed to acquire Mitsubishi Chemical Group’s pharmaceutical unit, adding to a dealmaking boom in Japan. The deal values Mitsubishi Tanabe Pharma at about ¥510 ...

The deal should close in the third quarter of 2025. Bain said in Friday’s announcement that Tanabe Pharma will now be an “independent company” and take on “new opportunities for growth ...

Works by Jean Paul Riopelle, Emily Carr, Tom Thomson and other titans of Canadian art history contributed to the evening’s total take of C$22.6m.

The U.S. investment company is in the final stages of negotiations to buy the subsidiary, Mitsubishi Tanabe Pharma, for possibly more than 500 billion yen, equivalent to $3.21 billion, the person ...